Public Policy Page Contents
- PSAB Documents (Statements, Reports, Testimony and Monthly Newsletters)
- Clinical Microbiology Resources
- Public and Scientific Affairs Board Information
- Federal and State Government Links
- Sentinel Level Clinical Laboratory Protocols For Suspected Biological Threat Agents And Emerging Infectious Diseases
- Committee on the Status of Women in Microbiology
- Committee on Microbiological Issues Impacting Minorities
- ASM Congressional Science Fellowship
ASM Policy efforts focus on communicating the importance of the microbial science to Congress, Federal Agencies and the Public.
What's New in Public Policy?
The December issue of the Minority Microbiology Mentor has been published by the Committee on Microbiological Issues Impacting Minorities (CMIIM).
The Office of Public Affairs has published the December issue of the e-Public Policy Update.
Janet Shoemaker and Kimberly Walker from ASM participated in a listening session with FDA Commissioner Robert Califf on rare diseases.
The 21st Century Cures Act passed the House of Representatives on November 30. It authorizes $4.8 billion over a ten year period for targeted initiatives at the NIH and $500 million for the FDA. The bill is expected to be voted on in the Senate the week of December 5. ...
The ASM and Pan American Society for Clinical Virology (PASCV) comment on reclassification of tests for the measurement of virus DNA levels in transplant-associated infections.
ASM, PEW, IDSA and BD sent a letter to Senate HELP Committee Chairman Alexander and Ranking Member Murray asking them to consider language to streamline the process for updating breakpoints as they work to finalize the 21st Century Cures innovation legislation.
The ASM, the Association for Molecular Pathology (AMP) and Pan American Society for Clinical Virology (PASCV) ask for data and clarification on the rRT-PCR assay for the testing of Zika, dengue and chikungunya viruses.
The October issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs.
The Committee on Laboratory Practices has developed a white paper to update members on colistin resistance and testing.
The ASM Office of Public Affairs has summarized the details of the Continuing Resolution that includes funding to combat Zika.